Core Viewpoint - A lawsuit has been filed against Molina Healthcare, Inc. and certain senior executives for potential violations of federal securities laws, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][2]. Group 1: Lawsuit Details - Investors have until December 2, 2025, to request to lead the case, which is pending in the U.S. District Court for the Central District of California [2]. - The lawsuit is titled Hindlemann v. Molina Healthcare, Inc., et al., No. 25-cv-9461 [2]. Group 2: Company Background - Molina Healthcare is a health insurance company that provides managed healthcare services to low-income individuals under Medicaid and Medicare programs [3]. - The company previously claimed a "solid" earnings growth profile heading into 2025 and stated it was able to mitigate negative effects of healthcare cost inflation [3]. Group 3: Financial Performance and Stock Impact - On July 7, 2025, Molina reported Q2 2025 adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [4]. - The company cut its guidance for expected adjusted earnings per share by 10.2% to a range of $21.50 to $22.50 per share [4]. - Following further revelations on July 23, 2025, Molina expected full-year 2025 adjusted earnings to be no less than $19.00 per diluted share, leading to a stock price drop of $32.03 per share, or 16.8%, from $190.25 to $158.22 [4].

Core Insights - Molina Healthcare (NYSE: MOH) is facing significant penalties due to a perceived reduction in profitability attributed to increased utilization costs in the managed healthcare industry [1] - The company is expected to be impacted by new rates for Medicaid [1] Company Summary - Molina Healthcare is currently experiencing challenges related to profitability, primarily driven by higher costs associated with healthcare utilization [1] - The market's perception of the company's financial health is negatively influenced by these rising costs [1] Industry Summary - The managed healthcare industry is witnessing increased utilization costs, which is affecting companies like Molina Healthcare [1] - Changes in Medicaid rates are anticipated to further impact the financial performance of companies within this sector [1]

Core Insights - Molina Healthcare (NYSE: MOH) is facing significant penalties due to a perceived reduction in profitability attributed to increased utilization costs in the managed healthcare industry [1] - The company is expected to be impacted by new rates for Medicaid [1] Company Summary - Molina Healthcare is currently experiencing challenges related to profitability, primarily driven by higher costs associated with healthcare utilization [1] - The market's perception of the company's financial health is negatively influenced by these rising costs [1] Industry Summary - The managed healthcare industry is witnessing increased utilization costs, which is affecting companies like Molina Healthcare [1] - Changes in Medicaid rates are anticipated to further impact the financial performance of companies within this sector [1]

Core Viewpoint - A securities class action lawsuit has been filed against Molina Healthcare, Inc. for allegedly making false and misleading statements regarding its financial health and operational assumptions during the Class Period from February 5, 2025, to July 23, 2025 [1][2]. Summary by Relevant Sections Allegations Against Molina Healthcare - The lawsuit claims that Molina's management failed to disclose material adverse facts about its medical cost trend assumptions [2] - It is alleged that there was a dislocation between premium rates and medical costs, impacting Molina's near-term growth [2] - The complaint suggests that Molina's financial guidance for fiscal year 2025 was likely to be cut due to these undisclosed issues [2] - Defendants' positive statements regarding the company's business and prospects were deemed materially misleading and lacked a reasonable basis [2] Lead Plaintiff Process - Investors who suffered losses can seek to be appointed as lead plaintiffs by December 2, 2025, through Kessler Topaz Meltzer & Check, LLP or other counsel [3] - The lead plaintiff represents the interests of all class members and selects counsel to direct the litigation [3] - Participation as a lead plaintiff does not affect the ability to share in any recovery from the lawsuit [3] Firm Background - Kessler Topaz Meltzer & Check, LLP has a reputation for prosecuting class actions and has recovered billions for victims of corporate misconduct [4] - The firm emphasizes its commitment to protecting investors and consumers from fraud and negligence [4]

Core Viewpoint - Molina Healthcare, Inc. is facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934, with claims centered around undisclosed adverse financial information and misleading guidance during a specific class period [1][4][5]. Company Overview - Molina Healthcare provides managed healthcare services primarily to low-income families and individuals through Medicaid, Medicare, and state insurance marketplaces [3]. Allegations of the Lawsuit - The lawsuit alleges that Molina Healthcare failed to disclose critical information regarding its medical cost trend assumptions and the dislocation between premium rates and medical costs [4]. - It is claimed that Molina's near-term growth relied on reduced utilization of various healthcare services, which was not communicated to investors [4]. - The lawsuit also states that Molina's financial guidance for fiscal year 2025 was likely to be significantly reduced due to these undisclosed factors [4]. Financial Performance and Impact - On July 7, 2025, Molina reported adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [5]. - Following this announcement, Molina Healthcare's stock price experienced a decline, attributed to the revelation of ongoing medical cost pressures [5]. - On July 23, 2025, Molina further cut its full-year 2025 earnings guidance, reporting a GAAP net income of $4.75 per diluted share for Q2 2025, an 8% decrease year-over-year, and projecting adjusted earnings of no less than $19.00 per diluted share for the full year [6]. - This announcement led to a nearly 17% drop in Molina's stock price, reflecting investor reaction to the challenging medical cost environment [6]. Legal Process - Investors who purchased Molina Healthcare securities during the class period have until December 2, 2025, to seek appointment as lead plaintiff in the class action lawsuit [1][7]. - The lead plaintiff will represent the interests of all class members and can select a law firm to litigate the case [7]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a prominent law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [8][9].

Core Insights - Molina Healthcare, Inc. (MOH) is scheduled to report its third-quarter 2025 results on October 22, 2025, with earnings estimated at $3.97 per share and revenues of $10.9 billion [1][7] Earnings Estimates - The earnings estimate for Q3 2025 indicates a year-over-year decrease of 33.9%, while the revenue estimate suggests a growth of 5.4% year over year [2] - For the full year 2025, the revenue estimate is $44.54 billion, reflecting a 9.6% increase year over year, but the earnings per share estimate is $18.87, indicating a decline of 16.7% year over year [3] Historical Performance - Molina Healthcare has beaten the consensus estimate in two of the last four quarters and missed twice, with an average surprise of negative 2.2% [4] Earnings Prediction Model - The current model does not predict an earnings beat for Molina Healthcare, as it has an Earnings ESP of 0.00% and a Zacks Rank of 4 (Sell) [5] Membership and Premiums - The Zacks Consensus Estimate for premiums indicates a growth of 6.3% year over year in Q3, with Medicare premiums expected to reach $1.5 billion, up 8% year over year [6][8] - Medicaid membership is projected to decrease by 2.8% year over year, while Medicare membership is expected to grow by 6.5% [8] Medical Care Ratio and Costs - The consensus mark for the medical care ratio (MCR) in the Marketplace is pegged at 84.67%, up from 73% a year ago, and the total MCR is expected to be 90.32%, up from 89.20% [8] - Rising costs and lower investment income are expected to impact earnings, with a projected 15.3% decline in investment income and over 6% increase in total operating expenses [9]

Core Viewpoint - Molina Healthcare, Inc. is facing significant financial challenges, leading to a class action lawsuit for investors who purchased securities during a specified period due to misleading information regarding earnings guidance and medical cost pressures [1][3]. Financial Performance - On July 7, 2025, Molina reported second quarter adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [3]. - The company cut its full-year 2025 adjusted earnings per share guidance by 10.2% at the midpoint, revising it from at least $24.50 per share to a range of $21.50 to $22.50 per share [3]. - Molina's stock price fell by $6.97 per share, or 2.9%, closing at $232.61 per share on July 7, 2025, following the earnings announcement [3]. Subsequent Developments - On July 23, 2025, Molina further reduced its full-year 2025 earnings guidance, now expecting adjusted earnings to be no less than $19.00 per diluted share, representing a 13.6% cut from the previous guidance [3]. - The company's GAAP net income for the second quarter was reported at $4.75 per diluted share, an 8% decrease year over year [3]. - Molina's stock price experienced a significant drop of $32.03 per share, or 16.84%, closing at $158.22 per share on July 24, 2025, after the second guidance cut [3]. Legal Actions - The Portnoy Law Firm is advising Molina investors about a class action lawsuit for those who bought securities between February 5, 2025, and July 23, 2025, with a deadline to file a lead plaintiff motion by December 2, 2025 [1][2].

Core Points - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with specific deadlines for filing lead plaintiff motions [1] RCI Hospitality Holdings, Inc. (NASDAQ: RICK) - Class period is from December 15, 2021, to September 16, 2025, with a lead plaintiff deadline of November 20, 2025 [2] - Allegations include materially false and misleading statements regarding tax fraud and bribery, which understated the legal risks and misled investors about the company's business prospects [2] Fortinet, Inc. (NASDAQ: FTNT) - Class period is from November 8, 2024, to August 6, 2025, with a lead plaintiff deadline of November 21, 2025 [3] - Allegations include misleading statements about the refresh cycle of products and the true number of upgradable firewalls, leading to materially misleading representations about the company's operations and prospects [3] Molina Healthcare, Inc. (NYSE: MOH) - Class period is from February 5, 2025, to July 23, 2025, with a lead plaintiff deadline of December 2, 2025 [4] - Allegations include failure to disclose adverse facts regarding medical cost trend assumptions and the company's financial guidance, which were materially misleading to investors [4] Marex Group plc (NASDAQ: MRX) - Class period is from May 16, 2024, to August 5, 2025, with a lead plaintiff deadline of December 8, 2025 [5] - Allegations include selling over-the-counter financial instruments to itself and inconsistencies in financial statements, leading to materially misleading representations about the company's business and operations [6]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Molina Healthcare, Inc. due to alleged violations of federal securities laws, encouraging affected investors to contact them before the December 2, 2025 deadline for lead plaintiff applications in a federal securities class action [4][6]. Summary by Sections Company Overview - Molina Healthcare, Inc. is a publicly traded company on the NYSE under the ticker MOH [4]. Allegations and Financial Impact - The complaint alleges that Molina and its executives made false or misleading statements regarding the company's medical cost trend assumptions and financial guidance for fiscal year 2025 [6]. - Specific issues cited include a dislocation between premium rates and medical costs, reliance on low utilization of various health services, and the likelihood of cutting financial guidance [6]. Financial Results and Stock Performance - On July 7, 2025, Molina announced second-quarter results with adjusted earnings of approximately $5.50 per share, leading to a 10.2% cut in full-year earnings guidance from at least $24.50 to a range of $21.50 to $22.50 per share [7]. - Following this announcement, Molina's stock price fell by $6.97, or 2.9%, closing at $232.61 per share [7]. - On July 23, 2025, Molina further reduced its full-year earnings guidance, reporting a GAAP net income of $4.75 per diluted share for the second quarter, an 8% decrease year-over-year, and cutting guidance to no less than $19.00 per diluted share [8][9]. - This led to a significant stock price drop of $32.03, or 16.84%, closing at $158.22 per share on July 24, 2025 [9]. Legal Proceedings - The deadline for investors to seek the role of lead plaintiff in the class action is December 2, 2025 [4]. - Any member of the putative class can move the court to serve as lead plaintiff or remain an absent class member without affecting their ability to share in any recovery [10]. Call for Information - Faruqi & Faruqi encourages anyone with information regarding Molina's conduct, including whistleblowers and former employees, to contact them [11].

Core Viewpoint - A securities class action lawsuit has been filed against Molina Healthcare, Inc. for allegedly making false and misleading statements regarding its financial health and operational performance during the Class Period from February 5, 2025, to July 23, 2025 [1][2]. Summary by Relevant Sections Allegations Against Defendants - The complaint claims that Molina's management failed to disclose critical adverse facts about the company's medical cost trend assumptions [2] - It is alleged that Molina was facing a dislocation between premium rates and medical cost trends [2] - The company's near-term growth was reportedly reliant on a lack of utilization of behavioral health, pharmacy, and inpatient and outpatient services [2] - As a result of these issues, Molina's financial guidance for fiscal year 2025 was likely to be significantly reduced [2] - The positive statements made by Molina's management regarding the company's business and prospects were deemed materially misleading and lacking a reasonable basis [2] Lead Plaintiff Process - Investors in Molina have until December 2, 2025, to seek appointment as a lead plaintiff representative for the class [3] - A lead plaintiff acts on behalf of all class members and typically has the largest financial interest in the case [3] - The decision to serve as a lead plaintiff does not affect an investor's ability to share in any recovery [3] Firm Background - Kessler Topaz Meltzer & Check, LLP is known for prosecuting class actions and has a reputation for recovering billions for victims of corporate misconduct [4] - The firm aims to protect investors and consumers from fraud and negligence by businesses [4]